Effects of Heart Rate Variability-guided Training vs Standard Aerobic Prescription on Cardiovagal Modulation and Cardiorespiratory Fitness in Coronary Artery Disease
ParaDox
Chronic Adaptations in Cardiovagal Modulation and Cardiorespiratory Fitness in Patients With Coronary Artery Disease to a 12-week Heart Rate Variability-guided Training vs Traditional Aerobic Prescription Program: Study Protocol for a Randomized Controlled Trial
1 other identifier
interventional
48
1 country
1
Brief Summary
Coronary artery disease (CAD) is associated with autonomic dysfunction and is characterized by reduced heart rate variability (HRV) and impaired heart rate recovery. Regular exercise improves cardiovascular outcomes in CAD, with high-intensity interval training (HIIT) showing superior benefits compared to moderate-intensity continuous training (MICT). However, the full potential of exercise is not used in the clinical context since some of the training principles are neglected, contributing to a high number of exercise non-responders. HRV-guided training has been identified as an alternative prescription technique for cardiovascular endurance exercise and has contributed to greater improvements compared to standard prescriptions. Thus, this study aims to assess the chronic effects of exercise on cardiovagal modulation, baroreflex sensitivity, arterial stiffness, and cardiorespiratory fitness in patients with CAD, specifically determining whether heart rate variability-guided training yields different outcomes compared to a traditional prescription in a 12-week exercise intervention. A total of 48 participants, will be recruited and randomized into one of 3 groups: high-intensity interval training (HIIT), moderate-intensity continuous training (MICT), and HRV-guided training. The intervention will consist of 12 weeks of supervised exercise, with 3 weekly sessions. Participants in the HRV-guided training group will have their exercise intensity adjusted based on their individual HRV profiles. Moderate- or high-intensity sessions are prescribed when the 7-day rolling average of LnRMSSD remains within the smallest worthwhile change (SWC). If it falls outside the SWC, low-intensity sessions or rest are recommended. In the HIIT group, sessions will consist of 4 bouts of 2 minutes at 80-90% HRR during the first 4 weeks, increasing to 6 bouts of 2 minutes at the same intensity in weeks 5-8, and progressing to 6 bouts of 2 minutes at 90% HRR in the final 4 weeks. In the MICT group, participants will perform continuous sessions starting with 2x10 minutes at 50-60% HRR in the first 4 weeks, progressing to 2x12 minutes at the same intensity in weeks 5-8, and increasing to 2x15 minutes at 60-70% HRR in the final phase. Cardiovagal modulation, cardiorespiratory fitness, BRS, and AS will be assessed at the baseline and after the 12 weeks of intervention. Most cardiac rehabilitation programs use the "one-size-fits-all" approach, which is a limitation of the literature, leading to a large number of exercise nonresponders to changes in cardiorespiratory fitness. HRV-guided training seems to be a more individualized method of aerobic prescription and may lead to greater improvements in cardiorespiratory fitness and in cardiovagal modulation. This study will contribute to generate evidence regarding aerobic exercise prescription in cardiac rehabilitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 30, 2025
CompletedFirst Posted
Study publicly available on registry
April 9, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2028
April 9, 2025
March 1, 2025
2.2 years
March 30, 2025
April 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Cardiovagal modulation
The R-R intervals will be derived from beat-to-beat blood pressure pulse intervals using finger plethysmography (Finapres Nova, Amsterdam, Netherlands), during all measures. Finger plethysmography-derived peak-to-peak intervals are highly correlated with electrocardiogram R-R intervals, with similar variability. The upstroke is determined using the pressure signal with a resolution of 2 ms, and the interval between the two consecutive upstrokes is measured. In the frequency domain, the two primary components are low-frequency (LF: 0.04-0.15 Hz) and high-frequency (HF: 0.15-0.40 Hz) spectra. Heart rate variability measures provide information primarily on vagal modulation with the LF power spectrum reflecting both sympathetic and parasympathetic modulation and HF reflecting the parasympathetic modulation of the R-R intervals. The LF/HF ratio is used as an indicator of sympathovagal dominance.
pre and post intervention (12 weeks) assessments
Cardiorespiratory fitness
An incremental CPET will be performed on a treadmill (Pulsar 3p, HP Cosmos) with mixing-chamber gas exchange measurements (Quark RMR w/CPET, Italy), according to Bruce modified protocol. A 12-lead electrocardiogram will be continuously monitored, and blood pressure will be assessed by auscultation using an aneroid sphygmomanometer. A cardiologist and an exercise physiologist will supervise the CPET. Before each test, the gas analyzer will be calibrated using ambient air standard calibration gases of known concentrations (16,7% O2 and 5,7% CO2). The turbine flowmeter of Cosmed will be calibrated with a 3L syringe. Data will be analyzed in 20 s average, and peak VO2 will be defined as the highest value attained in the last minute of effort
pre and post intervention (12 weeks) assessments
Secondary Outcomes (3)
Baroreflex sensitivity
pre and post intervention (12 weeks) assessments
Local arterial stiffness
pre and post intervention (12 weeks) assessments
Regional Arterial Stiffness
pre and post intervention (12 weeks) assessments
Other Outcomes (2)
Body composition
pre and post intervention (12 weeks) assessments
Free living physical activity
during one week
Study Arms (3)
HIIT (training/Behavioral)
EXPERIMENTALOver the first 4 weeks, participants will perform 4 bouts of 2 min of high-intensity exercise at 80-90% heart rate reserve (HRR), during the next 4 weeks, participants will perform 6 bouts of 2 min of high-intensity exercise at 80-90%HRR, while in the last 4 weeks participants will perform 6 bouts of 2 min of high-intensity exercise at 90%HRR). Exercise bouts will be interspersed by 2 min of active recovery at 50-60% HRR.
MICT (training/Behavioral)
EXPERIMENTALOver the first 4 weeks participants in MICT will perform continuous exercise at 50-60% HRR (2x10'), during the next 4 weeks participants will perform continuous exercise at 50-60% HRR (2x12'), while in the last 4 weeks participants will perform continuous exercise at 60-70% HRR (2x15').
HRV-Guided Training (training/Behavioral)
EXPERIMENTALFollowing a 10-day initial characterization period, where the HRV is measured with plethysmography continually during the night, with "Whoop" (https://www.whoop.com) device, the individual HRV profile is defined, still, participants will use the Whoop during all intervention to allow the updating of HRV profile. Then, considering the daily individual autonomic regulation, following a decision-making schema modified from Kiviniemi et al., (2007) \[21\], exercise intensity will be defined for the training session, i.e., if LnRMSSD7day-roll-avg remained inside the smallest worthwhile change (SWC) (SWC = 0.5 × standard deviation), high intensity or moderate-intensity training sessions is prescribed, if LnRMSSD7day-roll-avg fell outside SWC, low intensity or rest is prescribed, leading to different workloads from the predefined training programs.
Interventions
Over the first 4 weeks, participants will perform 4 bouts of 2 min of high-intensity exercise at 80-90% heart rate reserve (HRR), during the next 4 weeks, participants will perform 6 bouts of 2 min of high-intensity exercise at 80-90%HRR, while in the last 4 weeks participants will perform 6 bouts of 2 min of high-intensity exercise at 90%HRR). Exercise bouts will be interspersed by 2 min of active recovery at 50-60% HRR.
Over the first 4 weeks participants in MICT will perform continuous exercise at 50-60% HRR (2x10'), during the next 4 weeks participants will perform continuous exercise at 50-60% HRR (2x12'), while in the last 4 weeks participants will perform continuous exercise at 60-70% HRR (2x15').
Following a 10-day initial characterization period, where the HRV is measured with plethysmography continually during the night, with "Whoop" (https://www.whoop.com) device, the individual HRV profile is defined, still, participants will use the Whoop during all intervention to allow the updating of HRV profile. Then, considering the daily individual autonomic regulation, following a decision-making schema modified from Kiviniemi et al., (2007) \[21\], exercise intensity will be defined for the training session, i.e., if LnRMSSD7day-roll-avg remained inside the smallest worthwhile change (SWC) (SWC = 0.5 × standard deviation), high intensity or moderate-intensity training sessions is prescribed, if LnRMSSD7day-roll-avg fell outside SWC, low intensity or rest is prescribed, leading to different workloads from the predefined training programs.
Eligibility Criteria
You may qualify if:
- aged over 18 years;
- had angiographically documented CAD in at least one major epicardial vessel;
- clinical evidence of CAD in the form of previous myocardial infarction;
- clinical evidence of CAD in the form of coronary revascularization (coronary artery bypass grafting or percutaneous coronary intervention);
- clinical evidence of CAD in the form of angina pectoris.
You may not qualify if:
- heart failure;
- cardiac implantable defibrillators;
- resynchronizing devices;
- inability to comply with guidelines for participation in exercise testing and training.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculdade de Motricidade Humana
Lisbon, Lisbon District, 1495-688, Portugal
Related Publications (34)
Carrasco-Poyatos M, Gonzalez-Quilez A, Altini M, Granero-Gallegos A. Heart rate variability-guided training in professional runners: Effects on performance and vagal modulation. Physiol Behav. 2022 Feb 1;244:113654. doi: 10.1016/j.physbeh.2021.113654. Epub 2021 Nov 20.
PMID: 34813821BACKGROUNDKhan H, Kunutsor S, Rauramaa R, Savonen K, Kalogeropoulos AP, Georgiopoulou VV, Butler J, Laukkanen JA. Cardiorespiratory fitness and risk of heart failure: a population-based follow-up study. Eur J Heart Fail. 2014 Feb;16(2):180-8. doi: 10.1111/ejhf.37. Epub 2013 Dec 14.
PMID: 24464981BACKGROUNDKang SJ, Ko KJ. Association between resting heart rate, VO2max and carotid intima-media thickness in middle-aged men. Int J Cardiol Heart Vasc. 2019 Mar 29;23:100347. doi: 10.1016/j.ijcha.2019.100347. eCollection 2019 Jun.
PMID: 30976652BACKGROUNDEpelde F. Current Status, Challenges, and Future Directions in Cardiac Rehabilitation. Medicina (Kaunas). 2024 Feb 25;60(3):388. doi: 10.3390/medicina60030388.
PMID: 38541114BACKGROUNDRibeiro PAB, Boidin M, Juneau M, Nigam A, Gayda M. High-intensity interval training in patients with coronary heart disease: Prescription models and perspectives. Ann Phys Rehabil Med. 2017 Jan;60(1):50-57. doi: 10.1016/j.rehab.2016.04.004. Epub 2016 Jun 23.
PMID: 27346629BACKGROUNDPinto R, Angarten V, Santos V, Melo X, Santa-Clara H. The effect of an expanded long-term periodization exercise training on physical fitness in patients with coronary artery disease: study protocol for a randomized controlled trial. Trials. 2019 Apr 11;20(1):208. doi: 10.1186/s13063-019-3292-9.
PMID: 30975195BACKGROUNDMattioni Maturana F, Soares RN, Murias JM, Schellhorn P, Erz G, Burgstahler C, Widmann M, Munz B, Thiel A, Niess AM. Responders and non-responders to aerobic exercise training: beyond the evaluation of V O2max. Physiol Rep. 2021 Aug;9(16):e14951. doi: 10.14814/phy2.14951.
PMID: 34409753BACKGROUNDSanta-Clara H, Fernhall B, Mendes M, Sardinha LB. Effect of a 1 year combined aerobic- and weight-training exercise programme on aerobic capacity and ventilatory threshold in patients suffering from coronary artery disease. Eur J Appl Physiol. 2002 Oct;87(6):568-75. doi: 10.1007/s00421-002-0675-4. Epub 2002 Jul 30.
PMID: 12355198BACKGROUNDRakebrandt F, Palombo C, Swampillai J, Schon F, Donald A, Kozakova M, Kato K, Fraser AG. Arterial wave intensity and ventricular-arterial coupling by vascular ultrasound: rationale and methods for the automated analysis of forwards and backwards running waves. Ultrasound Med Biol. 2009 Feb;35(2):266-77. doi: 10.1016/j.ultrasmedbio.2008.08.013. Epub 2008 Nov 7.
PMID: 18992987BACKGROUNDStrauch AR, Berman MD, Miller HR. Substrate-associated macromolecules promote cytodifferentiation of BC3H1 myogenic cells. J Cell Physiol. 1991 Mar;146(3):337-48. doi: 10.1002/jcp.1041460302.
PMID: 1708777BACKGROUNDOhte N, Saeki T, Miyabe H, Sakata S, Mukai S, Hayano J, Niki K, Sugawara M, Kimura G. Relationship between blood pressure obtained from the upper arm with a cuff-type sphygmomanometer and central blood pressure measured with a catheter-tipped micromanometer. Heart Vessels. 2007 Nov;22(6):410-5. doi: 10.1007/s00380-007-0998-5. Epub 2007 Nov 26.
PMID: 18044000BACKGROUNDHeart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996 Mar 1;93(5):1043-65. No abstract available.
PMID: 8598068BACKGROUNDConraads VM, Pattyn N, De Maeyer C, Beckers PJ, Coeckelberghs E, Cornelissen VA, Denollet J, Frederix G, Goetschalckx K, Hoymans VY, Possemiers N, Schepers D, Shivalkar B, Voigt JU, Van Craenenbroeck EM, Vanhees L. Aerobic interval training and continuous training equally improve aerobic exercise capacity in patients with coronary artery disease: the SAINTEX-CAD study. Int J Cardiol. 2015 Jan 20;179:203-10. doi: 10.1016/j.ijcard.2014.10.155. Epub 2014 Oct 25.
PMID: 25464446BACKGROUNDPinto R, Melo X, Angarten V, Pires ML, Borges M, Santos V, Abreu A, Santa-Clara H. The effects of 12-months supervised periodized training on health-related physical fitness in coronary artery disease: a randomized controlled trial. J Sports Sci. 2021 Aug;39(16):1893-1902. doi: 10.1080/02640414.2021.1907062. Epub 2021 Mar 28.
PMID: 33775203BACKGROUNDKiviniemi AM, Hautala AJ, Kinnunen H, Tulppo MP. Endurance training guided individually by daily heart rate variability measurements. Eur J Appl Physiol. 2007 Dec;101(6):743-51. doi: 10.1007/s00421-007-0552-2. Epub 2007 Sep 12.
PMID: 17849143BACKGROUNDVesterinen V, Nummela A, Heikura I, Laine T, Hynynen E, Botella J, Hakkinen K. Individual Endurance Training Prescription with Heart Rate Variability. Med Sci Sports Exerc. 2016 Jul;48(7):1347-54. doi: 10.1249/MSS.0000000000000910.
PMID: 26909534BACKGROUNDManresa-Rocamora A, Sarabia JM, Javaloyes A, Flatt AA, Moya-Ramon M. Heart Rate Variability-Guided Training for Enhancing Cardiac-Vagal Modulation, Aerobic Fitness, and Endurance Performance: A Methodological Systematic Review with Meta-Analysis. Int J Environ Res Public Health. 2021 Sep 29;18(19):10299. doi: 10.3390/ijerph181910299.
PMID: 34639599BACKGROUNDKavanagh T, Mertens DJ, Hamm LF, Beyene J, Kennedy J, Corey P, Shephard RJ. Prediction of long-term prognosis in 12 169 men referred for cardiac rehabilitation. Circulation. 2002 Aug 6;106(6):666-71. doi: 10.1161/01.cir.0000024413.15949.ed.
PMID: 12163425BACKGROUNDKavanagh T, Mertens DJ, Hamm LF, Beyene J, Kennedy J, Corey P, Shephard RJ. Peak oxygen intake and cardiac mortality in women referred for cardiac rehabilitation. J Am Coll Cardiol. 2003 Dec 17;42(12):2139-43. doi: 10.1016/j.jacc.2003.07.028.
PMID: 14680741BACKGROUNDWitvrouwen I, Pattyn N, Gevaert AB, Possemiers N, Van Craenenbroeck AH, Cornelissen VA, Beckers PJ, Vanhees L, Van Craenenbroeck EM. Predictors of response to exercise training in patients with coronary artery disease - a subanalysis of the SAINTEX-CAD study. Eur J Prev Cardiol. 2019 Jul;26(11):1158-1163. doi: 10.1177/2047487319828478. Epub 2019 Feb 12.
PMID: 30755016BACKGROUNDCornish AK, Broadbent S, Cheema BS. Interval training for patients with coronary artery disease: a systematic review. Eur J Appl Physiol. 2011 Apr;111(4):579-89. doi: 10.1007/s00421-010-1682-5. Epub 2010 Oct 23.
PMID: 20972578BACKGROUNDVillelabeitia-Jaureguizar K, Vicente-Campos D, Senen AB, Jimenez VH, Garrido-Lestache MEB, Chicharro JL. Effects of high-intensity interval versus continuous exercise training on post-exercise heart rate recovery in coronary heart-disease patients. Int J Cardiol. 2017 Oct 1;244:17-23. doi: 10.1016/j.ijcard.2017.06.067. Epub 2017 Jun 17.
PMID: 28648356BACKGROUNDPiepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corra U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Lochen ML, Lollgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WMM, Binno S; ESC Scientific Document Group. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016 Aug 1;37(29):2315-2381. doi: 10.1093/eurheartj/ehw106. Epub 2016 May 23. No abstract available.
PMID: 27222591BACKGROUNDVanhees L, Rauch B, Piepoli M, van Buuren F, Takken T, Borjesson M, Bjarnason-Wehrens B, Doherty P, Dugmore D, Halle M; Writing Group, EACPR. Importance of characteristics and modalities of physical activity and exercise in the management of cardiovascular health in individuals with cardiovascular disease (Part III). Eur J Prev Cardiol. 2012 Dec;19(6):1333-56. doi: 10.1177/2047487312437063.
PMID: 22637740BACKGROUNDTaylor JL, Bonikowske AR, Olson TP. Optimizing Outcomes in Cardiac Rehabilitation: The Importance of Exercise Intensity. Front Cardiovasc Med. 2021 Sep 3;8:734278. doi: 10.3389/fcvm.2021.734278. eCollection 2021.
PMID: 34540924BACKGROUNDRauch B, Davos CH, Doherty P, Saure D, Metzendorf MI, Salzwedel A, Voller H, Jensen K, Schmid JP; 'Cardiac Rehabilitation Section', European Association of Preventive Cardiology (EAPC), in cooperation with the Institute of Medical Biometry and Informatics (IMBI), Department of Medical Biometry, University of Heidelberg, and the Cochrane Metabolic and Endocrine Disorders Group, Institute of General Practice, Heinrich-Heine University, Dusseldorf, Germany. The prognostic effect of cardiac rehabilitation in the era of acute revascularisation and statin therapy: A systematic review and meta-analysis of randomized and non-randomized studies - The Cardiac Rehabilitation Outcome Study (CROS). Eur J Prev Cardiol. 2016 Dec;23(18):1914-1939. doi: 10.1177/2047487316671181. Epub 2016 Oct 25.
PMID: 27777324BACKGROUNDSalzwedel A, Jensen K, Rauch B, Doherty P, Metzendorf MI, Hackbusch M, Voller H, Schmid JP, Davos CH. Effectiveness of comprehensive cardiac rehabilitation in coronary artery disease patients treated according to contemporary evidence based medicine: Update of the Cardiac Rehabilitation Outcome Study (CROS-II). Eur J Prev Cardiol. 2020 Nov;27(16):1756-1774. doi: 10.1177/2047487320905719. Epub 2020 Feb 23.
PMID: 32089005BACKGROUNDWinzer EB, Woitek F, Linke A. Physical Activity in the Prevention and Treatment of Coronary Artery Disease. J Am Heart Assoc. 2018 Feb 8;7(4):e007725. doi: 10.1161/JAHA.117.007725. No abstract available.
PMID: 29437600BACKGROUNDBadrov MB, Wood KN, Lalande S, Sawicki CP, Borrell LJ, Barron CC, Vording JL, Fleischhauer A, Suskin N, McGowan CL, Shoemaker JK. Effects of 6 Months of Exercise-Based Cardiac Rehabilitation on Autonomic Function and Neuro-Cardiovascular Stress Reactivity in Coronary Artery Disease Patients. J Am Heart Assoc. 2019 Sep 3;8(17):e012257. doi: 10.1161/JAHA.119.012257. Epub 2019 Aug 23.
PMID: 31438760BACKGROUNDAdams V, Reich B, Uhlemann M, Niebauer J. Molecular effects of exercise training in patients with cardiovascular disease: focus on skeletal muscle, endothelium, and myocardium. Am J Physiol Heart Circ Physiol. 2017 Jul 1;313(1):H72-H88. doi: 10.1152/ajpheart.00470.2016. Epub 2017 May 5.
PMID: 28476924BACKGROUNDKotecha D, New G, Flather MD, Eccleston D, Pepper J, Krum H. Five-minute heart rate variability can predict obstructive angiographic coronary disease. Heart. 2012 Mar;98(5):395-401. doi: 10.1136/heartjnl-2011-300033. Epub 2011 Nov 25.
PMID: 22121069BACKGROUNDHuikuri HV, Stein PK. Heart rate variability in risk stratification of cardiac patients. Prog Cardiovasc Dis. 2013 Sep-Oct;56(2):153-9. doi: 10.1016/j.pcad.2013.07.003. Epub 2013 Aug 12.
PMID: 24215747BACKGROUNDChen Y, Yu Y, Zou W, Zhang M, Wang Y, Gu Y. Association between cardiac autonomic nervous dysfunction and the severity of coronary lesions in patients with stable coronary artery disease. J Int Med Res. 2018 Sep;46(9):3729-3740. doi: 10.1177/0300060518778416. Epub 2018 Jun 25.
PMID: 29936852BACKGROUNDAdams V, Linke A, Krankel N, Erbs S, Gielen S, Mobius-Winkler S, Gummert JF, Mohr FW, Schuler G, Hambrecht R. Impact of regular physical activity on the NAD(P)H oxidase and angiotensin receptor system in patients with coronary artery disease. Circulation. 2005 Feb 8;111(5):555-62. doi: 10.1161/01.CIR.0000154560.88933.7E.
PMID: 15699275BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Helena Santa-Clara, PhD
Faculdade de Motricidade Humana
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator (PhD project)
Study Record Dates
First Submitted
March 30, 2025
First Posted
April 9, 2025
Study Start
September 1, 2025
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
June 1, 2028
Last Updated
April 9, 2025
Record last verified: 2025-03